Most sold healthcare stocks in Q2 2026
Discover which Healthcare stocks institutional investors trimmed or exited the most over Q2 2026 versus the prior calendar quarter in our filings. Notable reductions at the top of this list include AMICUS THERAPEUTICS INC (FOLD), HOLOGIC INC (HOLX), CENTESSA PHARMACEUTICALS-ADR (CNTA), APELLIS PHARMACEUTICALS INC (APLS). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Net share decreases
Top symbols by net quarter-over-quarter share change (decreases).
Most sold stocks
Net quarter-over-quarter share reductions across all institutional filers.
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| FOLD | AMICUS THERAPEUTICS INC | -310,990,108 | -$4.3B | 0 | 0 | 1 | 285 | 2 |
| HOLX | HOLOGIC INC | -200,739,384 | -$14.8B | 0 | 0 | 2 | 680 | 3 |
| CNTA | CENTESSA PHARMACEUTICALS-ADR | -142,813,837 | -$5.7B | 0 | 0 | 0 | 155 | 0 |
| APLS | APELLIS PHARMACEUTICALS INC | -136,876,549 | -$5.4B | 0 | 0 | 1 | 312 | 1 |
| MYGN | MYRIAD GENETICS INC | -123,165,819 | -$7.7M | 45 | 70 | 54 | 53 | 188 |
| TERN | TERNS PHARMACEUTICALS INC | -119,701,218 | -$6.2B | 0 | 0 | 0 | 302 | 1 |
| SGMO | SANGAMO THERAPEUTICS INC | -103,753,966 | -$25.7M | 3 | 1 | 0 | 106 | 6 |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | -81,252,014 | -$1.6B | 0 | 0 | 1 | 198 | 1 |
| KALV | KALVISTA PHARMACEUTICALS INC | -68,924,460 | -$1.4B | 1 | 0 | 0 | 179 | 1 |
| ACLX | ARCELLX INC | -55,605,062 | -$6.2B | 0 | 1 | 0 | 231 | 2 |
| SLNO | SOLENO THERAPEUTICS INC | -55,114,912 | -$1.8B | 0 | 0 | 0 | 218 | 0 |
| MASI | MASIMO CORP | -53,415,179 | -$9.4B | 0 | 0 | 2 | 434 | 2 |
| ASND | ASCENDIS PHARMA A/S - ADR | -52,381,041 | -$12.0B | 2 | 3 | 0 | 252 | 9 |
| IMUX | IMMUNIC INC | -50,380,292 | $59.6M | 12 | 2 | 40 | 33 | 55 |
| EHAB | ENHABIT INC | -46,414,572 | -$642.5M | 0 | 1 | 0 | 169 | 1 |
| RCEL | AVITA MEDICAL INC | -41,333,924 | -$50.8M | 23 | 22 | 19 | 27 | 71 |
| GSK | GSK PLC-SPON ADR | -29,763,228 | -$2.6B | 107 | 361 | 327 | 116 | 1001 |
| HRTX | HERON THERAPEUTICS INC | -26,684,229 | -$69.7M | 22 | 54 | 39 | 29 | 156 |
| IVVD | INVIVYD INC | -26,497,871 | -$119.0M | 35 | 36 | 26 | 47 | 124 |
| SCYX | SCYNEXIS INC | -24,666,362 | -$6.4M | 11 | 1 | 27 | 16 | 39 |
| VNRX | VOLITIONRX LTD | -20,447,187 | -$1.9M | 5 | 0 | 18 | 13 | 23 |
| CUE | CUE BIOPHARMA INC | -19,736,021 | $47.2M | 15 | 2 | 32 | 21 | 49 |
| MREO | MEREO BIOPHARMA GROUP PL-ADR | -18,745,430 | -$6.9M | 15 | 12 | 12 | 18 | 58 |
| ATYR | ATYR PHARMA INC | -17,743,750 | -$20.7M | 16 | 26 | 29 | 39 | 85 |
| BSX | BOSTON SCIENTIFIC CORP | -16,525,170 | -$23.0B | 155 | 557 | 596 | 359 | 1429 |
| GERN | GERON CORP | -16,004,416 | -$124.0M | 37 | 93 | 54 | 38 | 248 |
| CNTX | CONTEXT THERAPEUTICS INC | -15,698,868 | -$160.6M | 36 | 17 | 11 | 19 | 75 |
| BCAB | BIOATLA INC | -15,372,571 | -$1.3M | 5 | 0 | 16 | 19 | 21 |
| ZTS | ZOETIS INC | -14,408,020 | -$19.4B | 167 | 483 | 578 | 374 | 1376 |
| QNCX | QUINCE THERAPEUTICS INC | -14,062,046 | $15.1M | 14 | 3 | 8 | 28 | 25 |
| ABCL | ABCELLERA BIOLOGICS INC | -13,487,440 | $432.6M | 40 | 34 | 49 | 30 | 145 |
| NVS | NOVARTIS AG-SPONSORED ADR | -13,257,657 | -$1.5B | 130 | 505 | 558 | 140 | 1559 |
| SGRY | SURGERY PARTNERS INC | -12,863,658 | $540.2M | 35 | 71 | 47 | 34 | 179 |
| APGE | APOGEE THERAPEUTICS INC | -12,532,259 | $2.1B | 113 | 81 | 61 | 56 | 277 |
| PCVX | VAXCYTE INC | -11,935,301 | -$685.3M | 47 | 126 | 94 | 60 | 313 |
| QSI | QUANTUM-SI INC | -10,443,500 | -$26.2M | 29 | 32 | 54 | 45 | 138 |
| NMTC | NEUROONE MEDICAL TECHNOLOGIE | -9,731,307 | -$3.0M | 5 | 1 | 19 | 12 | 25 |
| EMBC | EMBECTA CORP | -9,277,842 | -$359.1M | 59 | 76 | 67 | 87 | 301 |
| PSTV | PLUS THERAPEUTICS INC | -9,136,481 | -$1.5M | 0 | 0 | 0 | 24 | 0 |
| SNY | SANOFI-ADR | -8,952,693 | -$1.5B | 88 | 202 | 284 | 130 | 685 |
| OLMA | OLEMA PHARMACEUTICALS INC | -8,820,377 | -$353.4M | 23 | 69 | 58 | 39 | 176 |
| OPCH | OPTION CARE HEALTH INC | -8,527,793 | -$1.2B | 76 | 126 | 118 | 83 | 354 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | -8,158,732 | $3.8B | 212 | 445 | 445 | 159 | 1303 |
| DYN | DYNE THERAPEUTICS INC | -7,857,712 | $572.6M | 48 | 84 | 71 | 36 | 233 |
| RVTY | REVVITY INC | -7,672,082 | $1.8B | 103 | 184 | 158 | 74 | 519 |
| SEM | SELECT MEDICAL HOLDINGS CORP | -7,632,155 | -$37.9M | 46 | 60 | 78 | 83 | 233 |
| ARAY | ACCURAY INC | -7,390,841 | -$9.8M | 28 | 29 | 28 | 43 | 106 |
| AMLX | AMYLYX PHARMACEUTICALS INC | -7,261,398 | $332.9M | 50 | 67 | 58 | 20 | 198 |
| CRDF | CARDIFF ONCOLOGY INC | -7,121,209 | -$17.1M | 22 | 31 | 24 | 37 | 98 |
| TVTX | TRAVERE THERAPEUTICS INC | -7,114,387 | $2.3B | 85 | 118 | 82 | 34 | 308 |